Clicky

Qilian International Holding Group Ltd.(QLI)

Description: Qilian International Holding Group Limited engages in the research, development, and production of active pharmaceutical ingredients (APIs) and traditional Chinese medicine derivative (TCMD) products in China. The company offers licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It also provides Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and sausage casings comprising Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to enhance crop yield and soil's chemical properties, and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to enhance plant growth. The company was incorporated in 2019 and is based in Jiuquan, the People's Republic of China.


Keywords: Pharmaceutical Disease Medication Health Sciences Pharmacology Active Pharmaceutical Ingredients Pharmaceutical Sciences Tablet Cardiovascular Disease Traditional Chinese Medicine Hemodialysis Sausage Casing Active Ingredient Cerebrovascular Diseases Liquorice Natural Food Products Licorice Products

Home Page: www.qlsyy.net

QLI Technical Analysis

Jiuquan Eco & Tech Dev Zn
Jiuquan, 735000
China
Phone: 86 02 8647 75180


Officers

Name Title
Mr. Zhanchang Xin Chairman, Pres, CEO, COO & Chief Scientific Officer
Ms. Haiping Shi CFO & Director

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 45
Price-to-Book MRQ: 0.7088
Price-to-Sales TTM: 0.6094
IPO Date: 2021-01-12
Fiscal Year End: September
Full Time Employees: 283
Back to stocks